GOLIMUMAB — A NEW TNF α-BLOCKER. THE REVIEW OF THE EFFICACY AND SAFETY EVALUATION RESULTS
The article represents the results of efficacy and safety evaluation of the human monoclonal antibodies — golimumab, according to the data of international multicenter randomized double-blind placebo-controlled trials, including patients with active stage of rheumatoid arthritis. It was shown, that...
| Autors principals: | , |
|---|---|
| Format: | Article |
| Idioma: | English |
| Publicat: |
"Paediatrician" Publishers LLC
2012-07-01
|
| Col·lecció: | Вопросы современной педиатрии |
| Matèries: | |
| Accés en línia: | https://vsp.spr-journal.ru/jour/article/view/449 |